Literature DB >> 15302355

Pathology of pulmonary hypertension.

Norbert F Voelkel1, Carlyne Cool.   

Abstract

This article briefly discusses the traditional concepts of severe pulmonary hypertension and then details how the concept of severe pulmonary hypertension has moved from a vasoconstrictive to an angioproliferative disorder.

Entities:  

Mesh：

Year:  2004        PMID： 15302355     DOI： 10.1016/j.ccl.2004.04.010

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN： 0733-8651            Impact factor:   2.213


  21 in total

1.  Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.

Authors:  Lahouaria Hadri; Razmig G Kratlian; Ludovic Benard; Bradley A Maron; Peter Dorfmüller; Dennis Ladage; Christophe Guignabert; Kiyotake Ishikawa; Jaume Aguero; Borja Ibanez; Irene C Turnbull; Erik Kohlbrenner; Lifan Liang; Krisztina Zsebo; Marc Humbert; Jean-Sébastien Hulot; Yoshiaki Kawase; Roger J Hajjar; Jane A Leopold
Journal:  Circulation       Date:  2013-06-26       Impact factor: 29.690

2.  Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.

Authors:  Monal Patel; Dan Predescu; Cristina Bardita; Jiwang Chen; Niranjan Jeganathan; Melanie Pritchard; Salvatore DiBartolo; Roberto Machado; Sanda Predescu
Journal:  Am J Pathol       Date:  2017-01-06       Impact factor: 4.307

3.  Role of Krüppel-like factor 4 in cigarette smoke-induced pulmonary vascular remodeling.

Authors:  Desheng Sun; Qinghai Li; Dandan Ding; Xiaochen Li; Min Xie; Yongjian Xu; Xiansheng Liu
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

4.  Pulmonary hypertension: diagnosis and management.

Authors:  Michael D McGoon; Garvan C Kane
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

Review 5.  The adventitia: essential regulator of vascular wall structure and function.

Authors:  Kurt R Stenmark; Michael E Yeager; Karim C El Kasmi; Eva Nozik-Grayck; Evgenia V Gerasimovskaya; Min Li; Suzette R Riddle; Maria G Frid
Journal:  Annu Rev Physiol       Date:  2012-12-03       Impact factor: 19.318

6.  Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension.

Authors:  Silvia Ulrich; Mark R Nicolls; Laima Taraseviciene; Rudolf Speich; Norbert Voelkel
Journal:  Respiration       Date:  2007-11-20       Impact factor: 3.580

7.  Senescent endothelial progenitor cells from dogs with pulmonary arterial hypertension: a before-after self-controlled study.

Authors:  Liang Xia; Jun-hui Zhu; Fu-yu Qiu; Ying Yang; Xu-dong Xie; Xing-xiang Wang; Jun-zhu Chen; Guo-sheng Fu
Journal:  J Physiol Sci       Date:  2009-07-28       Impact factor: 2.781

Review 8.  The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series).

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

9.  Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.

Authors:  Zhiyu Dai; Ming Li; John Wharton; Maggie M Zhu; You-Yang Zhao
Journal:  Circulation       Date:  2016-04-25       Impact factor: 29.690

10.  The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice.

Authors:  Lakshmi Kugathasan; Julie Basu Ray; Yupu Deng; Effat Rezaei; Daniel J Dumont; Duncan J Stewart
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.